This bill establishes new provisions regarding health benefit plans that cover advanced, metastatic cancer and associated conditions. It defines "advanced, metastatic cancer" as cancer that has spread from its original site and outlines "associated conditions" as symptoms or side effects that could further jeopardize a patient's health if untreated. The bill mandates that health benefit plans cannot require enrollees to have previously failed treatment with a different drug or to have a history of failure with another drug before covering a prescription drug approved by the FDA for treating advanced, metastatic cancer.

Additionally, the bill specifies that the coverage must apply only to drugs that are consistent with best practices for treating advanced, metastatic cancer, supported by peer-reviewed literature, and approved by the FDA. This legislation aims to improve access to necessary medications for patients suffering from advanced cancer without the burden of prior treatment failures. The act will take effect upon its publication in the statute book.